MedTrace Logo

Incidence of Opioid-Induced Respiratory Depression in Medical and Trauma Patients

NCT03647696 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-06-11

No results posted yet for this study

Summary

The primary objective of this prospective, blinded observational study is to correlate assessment of sedation and respiratory status with capnography and pulse oximetry monitoring in hospitalized adult medical and trauma patients receiving patient-controlled analgesia (PCA) or nurse administered intravenous (IV) opioids for acute pain. Nursing assessment of respiratory status and sedation level will be correlated with capnography and pulse oximetry values as technology-supported monitoring to identify respiratory depression and opioid-induced sedation. The secondary objective is to identify capnography and pulse oximetry values that correlate with respiratory decompensation and opioid-induced sedation in medical and trauma patients on the general care floor.

Conditions

  • Respiratory Depression
  • Sedation

Sponsors & Collaborators

Principal Investigators

  • Susan J Dempsey, PhD(c) · UCLA and UCHealth

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-30
Primary Completion
2018-08-30
Completion
2018-08-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03647696 on ClinicalTrials.gov